Dr. Juan Camilo Arjona Ferreira - 04 Oct 2022 Form 4 Insider Report for Myovant Sciences Ltd.

Role
Chief Medical Officer
Signature
/s/ Matthew Lang, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
04 Oct 2022
Net transactions value
-$66,807
Form type
4
Filing time
06 Oct 2022, 16:28:34 UTC
Previous filing
20 Jul 2022
Next filing
20 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYOV Common Shares Sale $66,807 -2,738 -1.1% $24.40 251,648 04 Oct 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.